We back tomorrow’s category-leading D2C health brands
Capital • Strategy • Execution •
Capital • Strategy • Execution •
We support founders where it actually matters
Capital
We invest our own capital into D2C health brands with proven product market fit – Typically at €1M+ annual revenue. Focused tickets. Clear ownership. Aligned incentives.
Knowledge
We bring hands on experience from building and scaling an eight figure D2C health brand in a competitive market. No theory. Only what has worked under real pressure.
Network
We open doors where it actually matters. Access to trusted partners across talent, manufacturing, fulfillment, compliance and growth marketing.
About WGNR Ventures
Michel Wagner is the managing director of WGNR Ventures and a serial D2C-entrepreneur
Founder with proven track record & >€10M in e-commerce sales
7+ years in leading and scaling vc-backed DTC-businesses
Scientific foundation in biomedical engineering & neuroscience
Owned the full stack: product, compliance, growth, operations, retention
PORTFOLIO COMPANIES
YAGCHO
•
AERIQ
•
YORA ORGANICS
•
YAGCHO • AERIQ • YORA ORGANICS •
Get in touch
WGNR Ventures partners with founders building category-leading consumer brands.
If you’re a founder with real traction or an operator with relevant investment opportunities, send us a short overview. We invest selectively and engage where we can add strategic value beyond capital.
WGNR Ventures GmbH
Baakenallee 64
D-20457 Hamburg
Germany
T +49 162 885 42 68
E michel@wgnr.vc
Managing Director: Michel WagnerCommercial Register: Amtsgericht Hamburg HRB 180922 EUID: DEK1101R.HRB180922